Benitec Biopharma Inc. (BNTC): Net Income
-$45.55M
Year ended 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$45.55M | n/m | 2026-09-14, From 2025-07-01 |
| 2025-06-30 | -$37.92M | n/m | 2026-09-14, From 2024-07-01 |
| 2024-06-30 | -$21.75M | n/m | 2026-03-20, From 2023-07-01 |
| 2023-06-30 | -$19.56M | n/m | 2024-09-26, From 2022-07-01 |
| 2022-06-30 | -$18.21M | n/m | 2023-09-21, From 2021-07-01 |
| 2021-06-30 | -$13.88M | n/m | 2022-09-02, From 2020-07-01 |
| 2020-06-30 | -$8.27M | n/m | 2021-09-20, From 2019-07-01 |
| 2019-06-30 | $2.61M | n/a | 2020-09-23, From 2018-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | 2026-06-30 | -$45.55M | n/m |
| Alto Neuroscience, Inc. (ANRO) | 2025-12-31 | -$63.24M | n/m |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | -$50.34M | n/m |
| Fortress Biotech, Inc. (FBIO) | 2025-12-31 | $6.82M | n/m |
| PepGen Inc. (PEPG) | 2025-12-31 | -$89.66M | n/m |
| Adicet Bio, Inc. (ACET) | 2025-12-31 | -$116.80M | n/m |
| Trevi Therapeutics, Inc. (TRVI) | 2025-12-31 | -$42.76M | n/m |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | -$170.37M | n/m |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | -$45.62M | n/m |
Compare BNTC, ANRO, LXRX, FBIO side by side · Screen every company in Pharmaceutical Preparations ↗